Abdominal Drainage, Postoperative Antibiotico-prophylaxis and CME With D3 Lyphadenectomy Effect on Gastrointestinal Function in Laparoscopic Right Hemicolectomy With Intracorporeal Anastomosis for Right Colon Cancer

November 20, 2023 updated by: Giuseppe Sigismondo Sica, University of Rome Tor Vergata
Monocentric, two-level factorial, parallel-arm, pilot randomized clinical trial, conducted comparing patients undergoing laparoscopic right hemicolectomy with ICA for right colon cancer in a single unit of a teaching hospital: Minimally Invasive Surgery Unit, Department of Surgical Sciences, Policlinico Tor Vergata, Rome, Italy.

Study Overview

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rome, Italy, 00133
        • University of Rome Tor Vergata

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Right colon cancer
  • Intracorporeal anastomosis
  • Laparoscopic surgery
  • Elective surgery
  • informed consent signed

Exclusion Criteria:

  • below 18 years old
  • IBD
  • ASA IV
  • T4b
  • Metastatic disease
  • Preoperative steroids
  • Conversion to open surgery
  • Emergency surgery
  • concomitant major operation
  • preoperative infective status
  • benign disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Abdominal drainage
19 Fr abdominal drainage placed intraoperatevely in right paracolic gutter
19 Fr abdominal drainage placed intraoperatively in right colic gutter
the dissection starts over the landmark given by SMV. The SMV is freed anteriorly and on its right-hand side from all the lympho-adipose tissue. Once the SMV is fully exposed, the IC vessels are dissected and divided at the junction with the efferent vessels. The dissection moves upward along the same dissection line to identify the right colic vein and the GCTH. No medial to later dissection is carried out until the SMV is completely exposed before reaching the uncinate process of the pancreas. At this point the veins to the right colon are divided but gastroepiploic vein and artery are preserved unless the tumor is located at the hepatic flexure. The divided mesentery is lifted and tilted to the right, and the medial-to-later dissection starts following the embryological plane over Fredet's fascia. The mesocolon is divided on the right side of the middle colic artery and the right branches of the middle colic vessels are divided.
A medial-to-lateral surgical dissection and high tie of the ileocolic vessels (IC) is undertaken without dissecting the anterior surface of the superior mesenteric vein (SMV). The gastro-colic trunk of Henle (GCTH) is not isolated and the right colic vein (when present) and the right branches of the middle colic vessels are taken more peripherical, during the division of the transverse mesocolon. The right gastroepiploic vessels are not dissected, nor divided, unless in proximity of the tumor
Experimental: Postoperative antibiotico-prophylaxis
postoperative antibiotico-prophylaxis with Ceftriaxone 2gr and Metronidazole 1.5gr
Ceftriaxone 2 gr and Metronidazole 1.5 gr per day for 2 days postoperatively
the dissection starts over the landmark given by SMV. The SMV is freed anteriorly and on its right-hand side from all the lympho-adipose tissue. Once the SMV is fully exposed, the IC vessels are dissected and divided at the junction with the efferent vessels. The dissection moves upward along the same dissection line to identify the right colic vein and the GCTH. No medial to later dissection is carried out until the SMV is completely exposed before reaching the uncinate process of the pancreas. At this point the veins to the right colon are divided but gastroepiploic vein and artery are preserved unless the tumor is located at the hepatic flexure. The divided mesentery is lifted and tilted to the right, and the medial-to-later dissection starts following the embryological plane over Fredet's fascia. The mesocolon is divided on the right side of the middle colic artery and the right branches of the middle colic vessels are divided.
A medial-to-lateral surgical dissection and high tie of the ileocolic vessels (IC) is undertaken without dissecting the anterior surface of the superior mesenteric vein (SMV). The gastro-colic trunk of Henle (GCTH) is not isolated and the right colic vein (when present) and the right branches of the middle colic vessels are taken more peripherical, during the division of the transverse mesocolon. The right gastroepiploic vessels are not dissected, nor divided, unless in proximity of the tumor
Sham Comparator: Control group
No drainage nor postoperative antibiotico-prophylaxis
the dissection starts over the landmark given by SMV. The SMV is freed anteriorly and on its right-hand side from all the lympho-adipose tissue. Once the SMV is fully exposed, the IC vessels are dissected and divided at the junction with the efferent vessels. The dissection moves upward along the same dissection line to identify the right colic vein and the GCTH. No medial to later dissection is carried out until the SMV is completely exposed before reaching the uncinate process of the pancreas. At this point the veins to the right colon are divided but gastroepiploic vein and artery are preserved unless the tumor is located at the hepatic flexure. The divided mesentery is lifted and tilted to the right, and the medial-to-later dissection starts following the embryological plane over Fredet's fascia. The mesocolon is divided on the right side of the middle colic artery and the right branches of the middle colic vessels are divided.
A medial-to-lateral surgical dissection and high tie of the ileocolic vessels (IC) is undertaken without dissecting the anterior surface of the superior mesenteric vein (SMV). The gastro-colic trunk of Henle (GCTH) is not isolated and the right colic vein (when present) and the right branches of the middle colic vessels are taken more peripherical, during the division of the transverse mesocolon. The right gastroepiploic vessels are not dissected, nor divided, unless in proximity of the tumor

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tolerance to solid diet
Time Frame: 30 days postoperatively
time to light diet tolerance
30 days postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
C-Reactive Proteine
Time Frame: 30 days postoperatively
measured mg/L in I and III POD
30 days postoperatively
White blood cell
Time Frame: 30 days postoperatively
measured thousands/mL in I and III POD
30 days postoperatively
Procalcitonine
Time Frame: 30 days postoperatively
measured ng/ml in III and V POD
30 days postoperatively
Days of hospitalization
Time Frame: 90 days postoperatively
number of days of hospitalization
90 days postoperatively
Readmission rate
Time Frame: 90 days postoperatively
rate of hospital readmission
90 days postoperatively
Mortality rate
Time Frame: 90 days postoperatively
postoperative mortality
90 days postoperatively
Surgical site infection rate
Time Frame: 30 days postoperatively
postoperative wound infection
30 days postoperatively
Anastomotic leak rate
Time Frame: 30 days postoperatively
postoperative Ileocolic anastomotic leakage
30 days postoperatively
Tolerance to liquid diet
Time Frame: 30 days postoperatively
time to clear fluid tolerance
30 days postoperatively
Time to first flatus
Time Frame: 30 days postoperatively
Time to first flatus postoperatively
30 days postoperatively
Time to first evacuation
Time Frame: 30 days postoperatively
Time to first evacuation postoperatively
30 days postoperatively
need of abdomen CTscan rate
Time Frame: 30 days postoperatively
need of abdomen CTscan
30 days postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2020

Primary Completion (Actual)

August 1, 2022

Study Completion (Actual)

August 1, 2023

Study Registration Dates

First Submitted

July 15, 2021

First Submitted That Met QC Criteria

July 25, 2021

First Posted (Actual)

July 27, 2021

Study Record Updates

Last Update Posted (Estimated)

November 22, 2023

Last Update Submitted That Met QC Criteria

November 20, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colon Cancer

Clinical Trials on abdominal drainage

Subscribe